It is well known that the administration of anti-PD-1 or anti-PD-L1 monoclonal antibodies leads to dramatic alterations in the tumor microenvironment, transforming “cold” non-inflamed tumors into “hot” T-cell-infiltrated tumors [130]. This evidence concerns the gene PDCD1 and neoplasm.